Delivery Order SPE2DB22D1106-SPE2DB25FEYD0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 2% Viscous Solution 100ML under a firm fixed-price contract valued at $6,361.57. The contract was awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,030.80 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lidocaine 2% Viscous in 15 ML cup unit dose format. This non-set-aside, firm fixed price contract is scheduled for completion by July 30, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,097.10, is for the supply of 100ml bottles of 2% Lidocaine Viscous Solution. The contract has a completion date of February 5, 2024 and was awarded on February 2, 2024. This delivery order does not have a set-aside designation and is part of a larger indefinite...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Lidocaine 2% Viscous Solution 100ML, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed-price arrangement with a ceiling value of $1,037.48 and a performance period through March 11, 2024. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine 2% viscous solution in 100ml quantities. The $2,178.33 firm fixed price Delivery Order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,437.99 to AmerisourceBergen Drug Corp for Lidocaine HCL 1% vials (10 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $4,020.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 50ml units. This firm fixed-price delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- This federal contract award, valued at $11,154.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 2% Viscous Solution in 100ml bottles. It is a Firm Fixed Price Delivery Order contract with a completion date of December 14, 2023. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562655056 - Lidocaine 2% Viscous Solution, 100 ML, with a ceiling value of $1,994.40 and a performance period through November 1, 2023. This is a firm fixed price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $2,419.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 2% Viscous Solution, a pharmaceutical product, to support military and federal healthcare programs. The contract has an ultimate completion date of November 17, 2023, and is a Firm Fixed Price Delivery Order. The award is associated with a larger...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYD0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.58 to AmerisourceBergen Drug Corp for the supply of Lidocaine 2% Viscous Solution in 100ml quantities. This contract, awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a firm fixed-price procurement with no set-aside designation. The award was competitively executed and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medical products to support military and veteran healthcare systems. The Lidocaine 2% Viscous Solution is a topical anesthetic commonly utilized in military and federal medical facilities for pain management and diagnostic procedures, reflecting the company's ongoing role as a pharmaceutical prime vendor for the federal government's extensive healthcare procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/16/25 |